Effect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND): a phase 3, randomised, double-blind, placebo-controlled trial with an open-label extension.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Jan Ilkowski Hans-Peter Hartung Gabriel Pardo Tjalf Ziemssen Bruno Gran Finn Sellebjerg |
| Publication date | March 12, 2018 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |